Lunar sees first-quarter sales jump 36%

Article

Bone densitometry firm Lunar reported sharply higher revenueslast week for its first quarter (end-September). The Madison,WI, company had sales of $12.4 million, up 36% compared to revenuesof $9.1 million in the same period last year. The company's net

Bone densitometry firm Lunar reported sharply higher revenueslast week for its first quarter (end-September). The Madison,WI, company had sales of $12.4 million, up 36% compared to revenuesof $9.1 million in the same period last year.

The company's net income took a hit due to the costs of litigationwith competitor Hologic, however. Lunar's net profit was $1.3million, down 15% compared to net income of $1.6 million in lastyear's first quarter. Lunar spent $773,000 in the quarter on legalcosts related to the litigation, which was settled last month(SCAN 10/11/95).

The strong revenue growth was due to increased sales of Lunar'sExpert and DPX x-ray bone densitometers, as well as sales of theArtoscan MRI scanner, according to president Dr. Richard Mazess.Lunar expects increased Expert shipments in upcoming quartersas component shortages ease and as U.S. physicians begin prescribingMerck's new Fosamax drug for treating osteoporosis.

Lunar's stock enjoyed a boost last week on news that Merck'slicensing agreement with competitor CompuMed might not be as lucrativefor CompuMed as was initially thought (SCAN 9/13/95). CompuMed'sstock dropped almost 50% when the company disclosed that the agreementincluded a royalty cap in the last two years of the contract.Shares of Lunar stock jumped 8% to $37 a share shortly after therevelation.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.